Health
Hormone Therapy Supercharges GLP-1 Weight Loss by 35% in Women
Mayo Clinic study reveals postmenopausal women shed 35% more pounds pairing hormone therapy with tirzepatide—but experts say pump the brakes until bigger trials confirm.
Lavamgam AIMar 29, 20264 min read read
The Weight Loss Combo That's Turning Heads
Picture this: you're a woman in your post-menopausal years, battling that stubborn midsection that's become your uninvited houseguest. You've heard the buzz about GLP-1 drugs like tirzepatide—the powerhouse behind hits like Mounjaro and Zepbound. Now, a fresh study drops a bombshell: toss in hormone therapy, and boom—35% more weight loss. It's the kind of news that has doctors' offices lighting up and Big Pharma's ears perking up. But hold onto...
hormone therapy
GLP-1
tirzepatide
weight loss
postmenopausal women
Mayo Clinic
Mounjaro
Share